Tumor-specific T cells from the TME are largely terminally differentiated (16) and express markers of exhaustion, such as PD-1, LAG-3, and TIM-3 (17, 18), limiting their functional antitumor activity. The gene discussed is PDCD1; the disease is neoplasm.